American Shared Hospital Services reported a significantly wider net loss in Q3 2026 compared to the prior year, despite a 13.7% increase in year-to-date revenue. The increased loss is attributed to operational costs and expenses related to a credit agreement amendment, indicating potential profitability challenges despite revenue growth.
American Shared Hospital Services (AMS) reported a net loss of $620,000 in Q3 2026, a substantial increase from the $17,000 loss in Q3 2025. This wider loss is a key concern for investors, even though year-to-date revenue grew by 13.7% to $23.1 million, driven by radiation therapy operations and Gamma Knife procedure volumes. The company cited expenses related to a credit agreement amendment as a contributing factor to the loss, suggesting ongoing financial restructuring or increased debt servicing costs. While cash flow from operations was positive ($5.8 million YTD) and cash balances increased, the inability to translate revenue growth into profitability in the quarter is a negative signal. Traders should consider the short-term negative implications of the wider loss against the long-term potential of revenue growth and cost optimization efforts, with the key risk being continued unprofitability despite operational improvements.